PAUL STEVEN M

Average Profitability
15.13%
Insider Buys Quantity
3
Insider Buys Sum
$651,380.00
Insider Sells Quantity
25
Insider Sells Sum
$67.06M

Insider Activity of PAUL STEVEN M

The largest purchase of all time was on 2016-01-14 and amounted to 20000 shares of Voyager Therapeutics, Inc. for $281,380.

The largest sale of all time was on 2018-03-06 and amounted to 116278 shares of Sage Therapeutics, Inc. for $20M.

Biography of PAUL STEVEN M

No biography is available at this moment.

2022-04-01SaleAlnylam Pharmaceuticals, Inc.
ALNY
90
<0.0001%
$174.33$15,690+18.01%
2020-12-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
15,000
0.0128%
$140.00$2.1M+19.4%
2020-02-10SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0263%
$130.00$3.9M+3.18%
2019-03-21SaleSage Therapeutics, Inc.
SAGE
director
7,879
0.0166%
$161.04$1.27M-1.3%
2019-03-20SaleSage Therapeutics, Inc.
SAGE
director
56,646
0.1236%
$161.29$9.14M+2.63%
2019-03-18SaleSage Therapeutics, Inc.
SAGE
director
3,775
0.008%
$161.05$607,977-0.26%
2019-03-01SaleSage Therapeutics, Inc.
SAGE
director
2,600
0.0054%
$161.00$418,600-0.73%
2019-02-25SaleSage Therapeutics, Inc.
SAGE
director
2,000
0.0042%
$161.00$322,000-0.58%
2019-02-19SaleSage Therapeutics, Inc.
SAGE
director
3,086
0.0067%
$161.62$498,746+3.78%
2019-02-15SaleSage Therapeutics, Inc.
SAGE
director
98,922
0.2041%
$161.02$15.93M-1.35%
2018-03-06SaleSage Therapeutics, Inc.
SAGE
director
116,278
0.2583%
$172.00$20M-15.13%
2016-01-14PurchaseVoyager Therapeutics, Inc.
VYGR
President and CEO
20,000
0.0801%
$14.07$281,380-11.93%
2015-09-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0703%
$52.41$1.05M-26.7%
2015-08-03SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0689%
$67.08$1.34M-38.19%
2015-07-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0697%
$69.40$1.39M-38.19%
2015-06-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0734%
$72.34$1.45M-35%
2015-05-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.07%
$53.31$1.07M-5.95%
2015-04-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0685%
$48.51$970,200+4.25%
2015-01-26PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
2,000
0.0024%
$95.00$190,000+10.43%
2014-07-23PurchaseSage Therapeutics, Inc.
SAGE
director
10,000
0.0334%
$18.00$180,000+46.89%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.